#1 Clinical Trials Search in Europe

Pioglitazone

Pioglitazone, also known by its brand name Actos, is a medication that has been the subject of numerous clinical trials exploring its potential benefits in various medical conditions. This article delves into the use of pioglitazone in clinical trials, examining its effects on diabetes, cancer prevention, cognitive function, and other health concerns. We’ll explore the drug’s mechanisms, potential benefits, and safety considerations across different patient populations.

Table of Contents

What is Pioglitazone?

Pioglitazone is a medication primarily used to treat type 2 diabetes. It belongs to a class of drugs called thiazolidinediones, which are also known as “insulin sensitizers”[1]. Pioglitazone is often sold under the brand name Actos[2]. This medication helps to control blood sugar levels in people with diabetes by making the body more sensitive to its own insulin, a hormone that regulates blood sugar.

Conditions Treated with Pioglitazone

While pioglitazone is primarily used for treating type 2 diabetes, research has shown that it may be beneficial for other conditions as well:

  • Polycystic Ovary Syndrome (PCOS): Pioglitazone has been studied for its potential to improve menstrual irregularities and reduce excess male hormones (hyperandrogenism) in women with PCOS[1].
  • Cancer Prevention: Some studies are investigating whether pioglitazone could help prevent certain types of cancer, such as head and neck cancer in patients with oral leukoplakia (white patches in the mouth that can sometimes develop into cancer)[3].
  • Brain Protection: Researchers are exploring if pioglitazone could help protect the brain from radiation-induced cognitive dysfunction in patients receiving radiation therapy for brain tumors[4].
  • Sepsis: There is ongoing research to determine if pioglitazone could help reduce inflammation in patients with severe sepsis and septic shock[5].

How Pioglitazone Works

Pioglitazone works by activating a specific protein in your cells called peroxisome proliferator-activated receptor-gamma (PPARγ)[1]. This protein helps your body:

  • Use insulin more effectively, which helps control blood sugar levels
  • Reduce inflammation throughout the body
  • Regulate fat storage and metabolism

By improving how your body responds to insulin, pioglitazone can help lower blood sugar levels in people with type 2 diabetes. Its anti-inflammatory effects are also being studied for potential benefits in other conditions.

Dosage and Administration

Pioglitazone is typically taken orally (by mouth) once daily. The dosage can vary depending on the condition being treated and the individual patient’s needs. Some common dosages seen in clinical trials include:

  • For diabetes: 30 mg or 45 mg once daily[6]
  • For PCOS: 30 mg once daily, potentially increased to 45 mg after 2 months if needed[1]
  • For research in other conditions: dosages may vary, but often start at lower doses like 15 mg or 22.5 mg daily[2]

Always follow your doctor’s instructions regarding dosage and administration. Do not adjust your dose without consulting your healthcare provider.

Potential Side Effects

Like all medications, pioglitazone can cause side effects. Some potential side effects include:

  • Fluid retention and weight gain: This is one of the most common side effects. It may lead to swelling (edema) in some patients[7].
  • Increased risk of heart failure: Especially in patients with existing heart problems[7].
  • Bone fractures: There may be an increased risk, particularly in women[7].
  • Liver problems: Rarely, pioglitazone can affect liver function[7].
  • Bladder cancer: Some studies have suggested a possible increased risk, although this is rare[7].
  • Low blood sugar (hypoglycemia): Especially when used with other diabetes medications[7].

It’s important to discuss potential side effects with your doctor and report any unusual symptoms you experience while taking pioglitazone.

Ongoing Research and Potential New Uses

Researchers are continually studying pioglitazone to understand its full potential. Some areas of ongoing research include:

  • Brain health: Studies are looking at how pioglitazone affects brain blood flow and cognitive function in elderly individuals[2].
  • Cancer prevention: Researchers are investigating if pioglitazone could help prevent certain types of cancer, particularly in high-risk individuals[3].
  • Inflammatory conditions: The anti-inflammatory properties of pioglitazone are being studied in conditions like sepsis[5].
  • Combination therapies: Studies are exploring how pioglitazone works when combined with other medications for diabetes and other conditions[8].

While these research areas are promising, it’s important to remember that pioglitazone is currently only approved for use in type 2 diabetes. Any other uses should be discussed with and supervised by a healthcare professional.

Aspect Details
Primary Uses Type 2 diabetes management, improving insulin sensitivity
Experimental Applications Cancer prevention, cognitive dysfunction prevention, asthma treatment, sepsis management
Administration Oral tablets, typically 15-45 mg daily
Duration of Studies Varies from several weeks to several months
Key Outcomes Measured Glycemic control, insulin sensitivity, inflammatory markers, cognitive function, renal function
Safety Monitoring Edema, weight gain, liver function, bone density, blood sugar levels
Potential Benefits Improved glycemic control, reduced inflammation, potential neuroprotective effects
Patient Populations Type 2 diabetes patients, cancer prevention candidates, brain tumor patients, asthma patients, sepsis patients

FAQ

  • What is pioglitazone and how does it work? Pioglitazone is a medication belonging to the thiazolidinedione class. It works by enhancing insulin sensitivity in muscle cells, adipose tissue, and liver cells, thereby improving glycemic control and reducing insulin resistance in patients with type 2 diabetes.
  • In which medical conditions is pioglitazone being studied? Pioglitazone is being studied in various conditions, including type 2 diabetes, head and neck cancer prevention, cognitive dysfunction prevention, asthma, and severe sepsis. Researchers are exploring its potential benefits beyond its primary use in diabetes management.
  • What are some potential side effects of pioglitazone? Some potential side effects of pioglitazone include fluid retention (edema), weight gain, and changes in blood sugar levels. In clinical trials, researchers closely monitor for these effects and other safety concerns, such as impacts on liver function and bone density.
  • How is pioglitazone administered in clinical trials? In most clinical trials, pioglitazone is administered orally in tablet form. The dosage and duration of treatment vary depending on the specific study and condition being investigated, ranging from daily doses of 15 mg to 45 mg for periods of several weeks to several months.
  • Are there any unique applications of pioglitazone being explored? Yes, researchers are exploring unique applications of pioglitazone beyond diabetes treatment. These include its potential in preventing radiation-induced cognitive dysfunction in brain tumor patients, reducing inflammation in asthma patients, and improving outcomes in patients with severe sepsis and septic shock.

Ongoing Clinical Trials on Pioglitazone

  • Study on the Effects of Ertugliflozin and Semaglutide on Heart Health in Patients with Type 2 Diabetes

    Recruiting

    1 1 1 1
    Investigated drugs:
    Italy

  • Study of Pioglitazone and Metformin combination treatment for patients with Metabolic Associated Fatty Liver Disease and prediabetes

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Effects of Empagliflozin, Pioglitazone, and Semaglutide for Patients with Type 2 Diabetes

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Sweden

  • Study on Pioglitazone for Improving Kidney Health in Patients with ANCA-Associated Vasculitis

    Recruiting

    1 1 1
    Investigated drugs:
    France

  • Evaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Czechia Germany Italy Romania Slovakia

  • A study testing pioglitazone for adults with non-segmental vitiligo to see if it works and is safe when used with light therapy

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study of Pioglitazone and Avelumab Combined with Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients with Complete Cytogenetic Response

    Not yet recruiting

    1 1 1
    Investigated drugs:
    France

  • Study on Switching from Dulaglutide to Tirzepatide for Adults with Type 2 Diabetes

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Belgium France Germany Romania

  • Study on Pioglitazone for Adults with Non-Segmental Vitiligo

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on Personalized Treatment Using Dapagliflozin, Dulaglutide, and Metformin for Patients with Uncontrolled Type 2 Diabetes

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Spain

Glossary

  • Pioglitazone: A medication belonging to the thiazolidinedione class, used primarily to treat type 2 diabetes by improving insulin sensitivity in various tissues.
  • Thiazolidinedione: A class of drugs that improve insulin sensitivity, used in the treatment of type 2 diabetes.
  • Glycemic control: The management of blood sugar levels in patients with diabetes.
  • Insulin resistance: A condition where the body's cells don't respond effectively to insulin, leading to high blood sugar levels.
  • Leukoplakia: White or gray patches that can develop on the tongue, inside of the cheeks, and gums, potentially indicating precancerous changes.
  • Cognitive dysfunction: Impairment in mental processes such as thinking, reasoning, and memory.
  • Sepsis: A life-threatening condition caused by the body's extreme response to an infection, potentially leading to tissue damage and organ failure.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Biomarker: A measurable indicator of a biological state or condition, often used to assess the effectiveness of a treatment.
  • BOLD fMRI: Blood Oxygen Level Dependent functional Magnetic Resonance Imaging, a technique used to measure brain activity by detecting changes in blood oxygenation and flow.
  • Hemoglobin A1c: A blood test that measures average blood sugar levels over the past 2-3 months, commonly used to diagnose and monitor diabetes.
  • Glomerular filtration rate: A measure of how well the kidneys are filtering waste from the blood, used to assess kidney function.

References

  1. https://clinicaltrials.gov/study/NCT03757923
  2. https://clinicaltrials.gov/study/NCT01456117
  3. https://clinicaltrials.gov/study/NCT00099021
  4. https://clinicaltrials.gov/study/NCT01151670
  5. https://clinicaltrials.gov/study/NCT01352182
  6. https://clinicaltrials.gov/study/NCT05028140
  7. https://clinicaltrials.gov/study/NCT00780234
  8. https://clinicaltrials.gov/study/NCT02753803